New and useful polymorph of anhydrous paroxetine hydrochloride

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/12 (2006.01) A61K 31/445 (2006.01)

Patent

CA 2187128

A new form of paroxetine hydrochloride anhydrous, designated as Form III, is provided having one or more of the following characteristics: Infrared spectra as shown in Schedules "A" and "B"; a DSC onset temperature of about 159°C; an X-ray powder diffraction pattern as shown in Schedule "D"; a melting point of between about 156°C to about 162°C; a bulk density exceeding about 0.6g/mL and a tapped density exceeding about 0.9g/mL.

On présente une nouvelle forme de chlorhydrate de paroxétine anhydre, appelée Forme III et possédant une ou plusieurs des caractéristiques suivantes : spectre infrarouge selon les Annexes « A » et « B »; température DSC de départ d'environ 159 °C; diffraction des rayons X par la méthode des poudres, selon l'Annexe « D »; point de fusion d'environ 156 à 162 °C; densité apparente dépassant environ 0,6 g/mL; densité dépassant à peu près 0,9 g/mL.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New and useful polymorph of anhydrous paroxetine hydrochloride does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New and useful polymorph of anhydrous paroxetine hydrochloride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New and useful polymorph of anhydrous paroxetine hydrochloride will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1722284

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.